Study of ALXN1840 Versus Standard of Care in Pediatric Participants With Wilson Disease

Condition:   Wilson Disease Interventions:   Drug: ALXN1840;   Drug: Standard of Care Sponsor:   Alexion Pharmaceuticals Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials